Rheumatoid arthritis (RA) is a chronic inflammatory disorder that affects joints and can lead to pain, stiffness, and joint deformities. Managing RA can be challenging, and researchers are constantly exploring new treatment options to improve the lives of patients. One such option being investigated is Hyperbaric Oxygen Therapy (HBO2).

The HBO2 Study

A recent pilot study sought to understand the effects of HBO2 as a treatment for RA. The study involved ten individuals with RA who underwent 30 HBO2 sessions over 6 to 10 weeks. Researchers conducted regular rheumatologic evaluations throughout the study and at a 6-month follow-up.

Promising Results

The study yielded encouraging findings. Over time, HBO2 therapy had a statistically significant impact on key RA measures, including the Disease Activity Scale (DAS28), C-reactive protein levels, and erythrocyte sedimentation rate. These improvements were particularly significant for individuals who weren’t in clinical remission at the beginning of the study.

Reduced Pain

Besides improvements in RA indicators, the study also noted a significant reduction in pain levels based on the Routine Assessment of Patient Index Data 3 and the Pain and Sleep Quality Questionnaire. This suggests that HBO2 therapy may offer relief from the joint pain associated with RA.


For those living with the challenges of rheumatoid arthritis, the results of this pilot study provide a glimmer of hope. Hyperbaric Oxygen Therapy shows potential as a non-invasive and possibly effective treatment option. As researchers continue their investigations, there’s optimism that new avenues for managing RA may emerge, offering relief and improved quality of life for patients.

At Hyperbaric Central, we’re committed to keeping you informed about the latest developments in hyperbaric medicine. As research unfolds and new possibilities emerge, we’ll be here to share the insights that matter most to you.